NCT00990652 Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide Status COMPLETED Phase PHASE2
NCT00979017 Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00977431 Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform Status COMPLETED Phase PHASE1
NCT00970996 Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT00967330 A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma Status COMPLETED Phase PHASE2
NCT00961844 Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma Status TERMINATED Phase PHASE1/PHASE2
NCT00960492 Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma Status COMPLETED Phase PHASE1
NCT00960063 A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) Status TERMINATED Phase PHASE1
NCT00946335 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Status COMPLETED Phase PHASE1
NCT00943826 A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT00943462 Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM Status WITHDRAWN Phase N/A
NCT00916409 Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Status COMPLETED Phase PHASE3
NCT00915694 Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme Status TERMINATED Phase PHASE1
NCT00905060 HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM Status COMPLETED Phase PHASE2
NCT00892385 Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00890786 A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas Status COMPLETED Phase EARLY_PHASE1
NCT00884741 Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT00876993 Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors Status COMPLETED Phase PHASE1